Opioid Use to Treat Migraine Headaches in Hospitalized Children and Adolescents.
Journal
Hospital pediatrics
ISSN: 2154-1671
Titre abrégé: Hosp Pediatr
Pays: United States
ID NLM: 101585349
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
pubmed:
17
4
2020
medline:
31
7
2021
entrez:
17
4
2020
Statut:
ppublish
Résumé
Prescription of opioids to treat pediatric migraine is explicitly discouraged by treatment guidelines but persists in some clinical settings. We sought to describe rates of opioid administration in pediatric migraine hospitalizations. Using data from the Pediatric Health Information System, we performed a cross-sectional study to investigate the prevalence and predictors of opioid administration for children aged 7 to 21 years who were hospitalized for migraine between January 1, 2016, and December 31, 2018. There were 6632 pediatric migraine hospitalizations at 50 hospitals during the study period, of which 448 (7%) had an opioid administered during the hospitalization. There were higher adjusted odds of opioid administration in hospitalizations for non-Hispanic black (adjusted odds ratio [aOR], 1.68; Opioids continue to be used during pediatric migraine hospitalizations and are associated with longer lengths of stay and readmissions. These findings reveal important opportunities to improve adherence to migraine treatment guidelines and minimize unnecessary opioid exposure, with the potential to improve hospital discharge outcomes.
Identifiants
pubmed: 32295812
pii: hpeds.2020-0007
doi: 10.1542/hpeds.2020-0007
pmc: PMC7187393
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
401-407Subventions
Organisme : NICHD NIH HHS
ID : K23 HD083405
Pays : United States
Informations de copyright
Copyright © 2020 by the American Academy of Pediatrics.
Déclaration de conflit d'intérêts
POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.
Références
J Pediatr. 2019 Jan;204:240-244.e2
pubmed: 30274923
Pediatr Emerg Care. 2019 Jun 22;:
pubmed: 31246788
Pediatrics. 2015 Dec;136(6):e1521-9
pubmed: 26574588
JAMA Netw Open. 2018 Dec 7;1(8):e186558
pubmed: 30646334
J Hosp Med. 2014 Sep;9(9):565-72
pubmed: 24913444
Neurology. 2019 Sep 10;93(11):487-499
pubmed: 31413171
J Pediatr. 2016 Dec;179:211-215
pubmed: 27634627
Am J Epidemiol. 1998 Sep 1;148(5):475-86
pubmed: 9737560
BMC Pediatr. 2014 Aug 08;14:199
pubmed: 25102958
Cephalalgia. 2013 Jul;33(9):629-808
pubmed: 23771276
Cochrane Database Syst Rev. 2016 Apr 19;4:CD005220
pubmed: 27091010
J Pain Symptom Manage. 2014 Nov;48(5):903-14
pubmed: 24703942
J Adolesc Health. 2014 Jul;55(1):128-33
pubmed: 24581795
Pediatrics. 2018 Apr;141(4):
pubmed: 29523706
J Hosp Med. 2018 Apr 25;13(9):602-608
pubmed: 29694460
Pediatrics. 2017 Sep;140(3):
pubmed: 28765382
Neurol Sci. 2013 May;34 Suppl 1:S125-8
pubmed: 23695060
Adv Radiat Oncol. 2018 May 04;3(3):221-229
pubmed: 30202793
Pediatrics. 2018 Jun;141(6):
pubmed: 29853621
Pediatrics. 2010 Dec;126(6):1108-16
pubmed: 21115581
J Pain. 2017 Oct;18(10):1270-1276
pubmed: 28652205
JAMA Pediatr. 2016 Dec 1;170(12):1195-1201
pubmed: 27802492
JAMA Netw Open. 2018 Dec 7;1(8):e186161
pubmed: 30646317